Limitations of Conventional Arm and Hand Therapy
- Severity prevents practice
- Difficult to keep patients motivated
- Limited number of repetitions
- Therapy limited by availability of therapists
- Unclear feedback regarding progress and performance
- Changing needs of patients
Advantages of ArmeoPower Exercise
Highly Intensive Early Arm Rehabilitation
The ArmeoPower has been specifically designed for arm and hand therapy in an early stage of rehabilitation.
The device enables even patients with severe motor impairments to perform exercises with a high number of repetitions.
Adjustable Robotic Assist during Exercises
The ArmeoPower assists the patient’s arm as much as needed to successfully reach the goal of the exercise.
The robotic arm assistance can be adapted to the individual needs and changing abilities of each patient – from full assistance for patients with very little activity to no assistance at all for more advanced patients. Such adjustable robotic assistance while exercising, enables and motivates patients to actively participate in their training.
Arm weight support in an extensive workspace
The ArmeoPower carries the weight of the patient’s arm and hand and allows training in an extensive workspace.
The ArmeoPower supports 1D (joint-specific), 2D and 3D movements.
Motivating Exercises
An extensive library of game-like Augmented Performance Feedback exercises has been designed to train strength and range of motion needed for activities of daily living.
Immediate performance feedback motivates patients and helps to improve their motor abilities.
Increased Efficiency
The ArmeoPower improves efficiency of the therapy session by reducing the therapist’s physical effort and the need for continuous therapeutic guidance.
Moreover, the ArmeoPower enables therapists to make better use of their clinical know-how and expertise, by focusing on the optimal exercise planning, instead of manually delivering many repetitions.
Objective Assessments
The ArmeoPower precisely records how patients perform during their therapy sessions.
Standardized Assessment Tools evaluate a patient’s motor functions such as joint range of motion and forces. The results can be used to analyze and document the patient’s state and therapy progress. Results can then be shared with the patient and other clinicians.
Hand Training (Optional)
The ManovoPower enables severely impaired patients to exercise hand opening and closing through different levels of support.
The Augmented Performance Feedback exercises motivate patients to exercise hand opening and closing with high effort.
Part of a Modular Therapy Concept
The ArmeoPower is part of the modular Armeo Therapy Concept, an upper extremity concept that covers the “Continuum of Rehabilitation” throughout a range of devices, each developed for a specific stage of rehabilitation – from acute rehabilitation to long-term recovery.
Success Stories
Benefits of the Armeo®Power are Recognized All Over the World
Reference Centers
ArmeoPower is a highly advanced arm and hand rehabilitation device for early-stage patients even before they develop active movement.
ArmeoPower Modules
Scientific Evidence of Arm and Hand Rehabilitation with ArmeoPower
More than 60 studies have been conducted on the ArmeoPower, including the research versions of the device.
- Highly Intensive Early Arm Rehabilitation.
The device enables even patients with severe movement impairments to perform exercises with high intensity.
(Staubli et al. 2009)
- Adjustable Robotic Assist during Exercises.
The ArmeoPower assists the patient’s arm as much as needed to successfully reach the goal of the exercise.
(Nef et al. 2009)
What Experts Say
Improve Efficiency & Intensity
Earlier Start of Therapy
Increased Number of Repetitions
Enables Therapist to Supervise More Than One Patient at a Time
“In a way, 3D-robots plus games becomes your own arcade that is customized to you as the patient. I just don’t see where that is anywhere comparable to about twenty repetitions that are done by a therapist holding your arm. So it’s a qualitative difference.”
John W. Krakauer,
Professor of Neurology and Neuroscience, Johns Hopkins University School of Medicine
